Drreddys Laboratories | RDY - Ordinary Share Capital


Drreddys Laboratories reported INR832.57M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
ANI Pharmaceuticals USD 21.73M 21.73M Jun/2025
Aurora Cannabis CAD 6.98B 907K Dec/2024
Bayer EUR 982.42M 0 Sep/2025
Canopy Growth CAD 332.38M 127.23M Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Corcept Therapeutics USD 105.12M 164K Sep/2025
Drreddys Laboratories INR 832.57M 53K Dec/2025
GlaxoSmithKline GBP 4.03B 119.13M Sep/2025
Hikma Pharmaceutical USD 40M 0 Dec/2024
Lonza CHF 72M 0 Dec/2024
Novartis USD 1.94B 23.4M Jun/2025
Pacira USD 44.9M 44.85M Jun/2025
Prestige Brands USD 48.08M 47.52M Sep/2025
Richter Gedeon HUF 179.35M 18.46B Sep/2025
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
Supernus Pharmaceuticals USD 57.12M 1000K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025